Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2021

Jun 2, 2021

29875_dirs_2021-06-02_891e4219-6b8c-4c72-8b5f-121f55723415.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-05-28

Reporting Person: GUERTIN SHAWN M (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-28 Common Stock (restricted) A 34706 $86.44 Acquired 34706 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-05-28 Stock Option $1.00 A 97562 Acquired 2031-05-28 Common Stock (97562) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 9260 Direct

Footnotes

F1: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse 5/28/2024.

F2: Option becomes exercisable in four equal annual installments, commencing 5/28/2022.